Stevanato Group
✦ Quant Fair Value how this is computed
- Implied fair-value range of 11.36-28.36, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is -21.2% below the average-multiple fair value of 19.86.
Valuation each multiple against its own 5-year range
Vs. peers Medical Instruments & Supplies
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Stevanato Group (STVN) | 4.27B | 28.00 | 2.45 | 0.39% |
| Intuitive Surgical (ISRG) | 138.33B | 48.25 | 8.65 | 0.00% |
| Becton Dickinson & Co (BDX) | 57.96B | 52.02 | 2.35 | 1.97% |
| Alcon (ALC) | 35.92B | 54.24 | 1.64 | 0.48% |
| ResMed (RMD) | 33.14B | 21.46 | 5.57 | 1.04% |
| Medline (MDLN) | 32.55B | 57.52 | 2.76 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 5.4% below Morningstar's fair value estimate.
Fair value
Stevanato Group SpA is assigned a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 4% discount to our quantitative fair value estimate of $16.50 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.
We need more explanatory data to elaborate on this stock's star rating. We strive to explain the factors driving every rating we assign; however, this is not yet possible for a small fraction of our coverage universe.
Economic moat
The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-11-20 16:10:04 · For reference only, not investment advice and not tailored to your situation.
Stevanato Group discussion 0 comments